• 생명과학회지
• /
• 제13권2호
• /
• pp.214-222
• /
• 2003

고분자 중합체를 생산 능력이 있는 균주를 토양에서부터 분리하여 형태학적 및 생화학적인 특성을 확인하고 Bacillus 속 균주를 동정하는 API-50CH/B kit를 사용하여 동정한 결과, Bacillus coagulans로 확인되어 B. coagulans DL-1으로 명명하였며 고분자 중합체를 생산하여 체외로 분비하는 균주임을 확인하였다. 플라스크 실험을 통하여 고분자 중합체 생산을 위한 B. coagulans DL-1의 최적 탄소원과 질소원 및 각각의 최적 농도는 2% (w/v) 포도당과 0.25%(w/v) yeast extract임을 확인하였다. 플라스크 실험에서 확립한 최적 배지조건과 1.0 vvm의 통기량 및 500 rpm의 교반속도로 $7\ell$ 생물배양기를 사용하여 수행한 회분식 배양에서의 최대 고분자 중합체 생산량은 5.00$\pm$0.15 g/$\ell$이었다. 가스 크로마토그라피를 사용하여 B. coagulans DL-1이 생산한 고분자 중합체의 구성 성분을 분석한 결과, 포도당과 람노오스로 구성되어 있으며 포도당과 람노오스의 구성 비율은 약 9 : 1 이었다. 또한 평균 분자량을 gel permeation chromatography로 측정한 결과, 2.80$\times$$10^5$이었다.

• 생명과학회지
• /
• 제28권11호
• /
• pp.1347-1353
• /
• 2018

본 연구는 한국전통약용식물(구기자, 오미자 잎)의 발효물로부터 분리한 Bacillus coagulanse NRR1207의 발효 특성을 파악하고 Bacillus coagulans NRR1207의 ${\alpha}$-galactosidase의 활성과 이를 통한 대두박의 비소화성분의 분해를 확인하였다. Bacillus coagulans NRR1207이 생산하는 효소 중 ${\alpha}$-galactosidase, ${\beta}$-galactosidase, ${\alpha}$-glucosidase가 가장 높은 40 nmol 이상의 활성을 나타내었다. Bacillus coagulans NRR1207의 발효 특성은 10% skim milk에서 배양했을 때, pH는 급속히 감소했고 적정 산도는 1.9%까지 증가했고 생균수도 발효 24시간에 8.8 log CFU/ml로 증가했다. 유당은 배양 72시간째 완전히 고갈되었고 유산 생산 능력도 탁월했다. Bacillus coagulans NRR1207을 대두박에 접종 후 배양시간에 따른 생균수의 변화는 배양 시작 시 7.6 log CFU/ml, 배양 16시간에 최고에 도달하여 9.0 log CFU/ml이었고 배양 72시간에 8.3 log CFU/ml로 Bacillus coagulans NRR1207이 왕성하게 잘 성장하였다. 대두박의 비소화성분 분해는 Bacillus coagulans NRR1207 접종 후 발효 24, 48, 72시간이 경과하면서 이 균이 생산한 ${\alpha}$-galactosidase에 의해 비소화성분인 stachyose와 raffinose가 대부분 분해되고 galactose가 생성되었다. 따라서 Bacillus coagulans NRR1207은 대두박의 비소화성분을 분해하는 생균제(Probiotics)로써 이용하여 식품 및 가축 사료 이용성 증대에 활용이 가능할 것으로 사료된다.

• 약학회지
• /
• 제41권4호
• /
• pp.450-455
• /
• 1997

The preparation of Bacillus coagulans is used as a therapeutics for human intestinal disorders. However, the bacterium in the preparation is very susceptible to rifampic in and fluoroquinolones. When the preparation is taken with rifampicin or fluoroquinolones, its therapeutic effect can not be expected. So B. coagulans RFR17 resistant to rifampicin was obtained by treating the parent B. coagulans with N-methyl-N'-nitro-N-nitrosoguanidine. B. coagulans OFR17 was produced by serial passage of B. coagulans RFR17 on agar with 2-fold minimal inhibitory concentration of ofloxacin or ciprofloxacin. B. coagulans OFR17 was resistant to fluoroquinolones up to 16~64 fold higher than that for the original strain. B. coagulans OFR17 also exhibited identical characteristics with the parent strain when they were tested for lactic acid production and growth inhibition of E. coli MB4-01 and Shigella sonnei MB4-10411. From in vitro test, it was also identified that rifampicin and ofloxacin are not inactivated by certain factors of B. coagulans OFR17. Conclusively, B. coagulans OFR17 can be regarded as a promising strain which can be developed as the preparation for the treatment of the intestinal disorders of the tuberculosis patients under rifampicin and ofloxacin therapy.

• Journal of Microbiology and Biotechnology
• /
• 제32권2호
• /
• pp.212-219
• /
• 2022

Recently, the efficacy of probiotics in treatment of neurodegenerative disorders has been reported in animal and clinical studies. Here, we assessed the effects of Bacillus coagulans JA845 in counteracting the symptoms of D-galactose (D-gal)/AlCl₃-induced Alzheimer's disease (AD) in a mice model through behavioral test, histological assessment and biochemical analysis. Ten weeks of pre-treatment with B. coagulans JA845 prevented cognitive decline, attenuated hippocampal lesion and protected neuronal integrity, which demonstrated the neuroprotective features of B. coagulans JA845 in vivo. We also found that supplementation of B. coagulans JA845 alleviated amyloid-beta deposits and hyperphosphorylated tau in hippocampus of D-gal/AlCl₃-induced AD model mice. Furthermore, B. coagulans JA845 administration attenuated oxidative stress and decreased serum concentration of inflammatory cytokines by regulating the Nrf2/HO-1 and MyD88/TRAF6/NF-κB pathway. Our results demonstrated for the first time that B. coagulans has the potential to help prevent cognitive decline and might be a novel therapeutic approach for the treatment of neurodegenerative diseases.

• 한국미생물·생명공학회지
• /
• 제43권4호
• /
• pp.401-404
• /
• 2015

Bacillus coagulans는 프로바이오틱스 및 내열성 생물소재의 생산에 활용 가능성이 높은 미생물로 주목받고 있지만, 우리나라에서는 관심의 대상이 되지 못하고 있으며 상용화된 바 없다. 따라서 기능연구를 통한 산업화 대상 균주가 국내에는 충분히 확보되지 못한 상태에 있다. 본 연구자들은 미래 활용을 위한 B. coagulans의 확보를 위하여 볏짚으로부터 B. coagulans의 빠른 분리법을 개발하였다. $50^{\circ}C$에서의 집적배양, 산 생성 확인을 통한 Bacillus 속 균주의 제거, 선택배지를 이용한 enterococci 균주의 제거는 B. coagulans 선발을 위한 빠르고 정확한 방법이 될 수 있는 것으로 확인되었다.

• 한국수산과학회지
• /
• 제47권5호
• /
• pp.516-521
• /
• 2014

A bacterium producing ${\alpha}$-galactosidase (${\alpha}$-$\small{D}$-galactoside galactohydrolase, EC 3.2.1.22) was isolated. The isolate, KM-1 was identified as Bacillus coagulans based on its 16S rRNA sequence, morphology, and biochemical properties. ${\alpha}$-Galactosidase activity was detected the culture supernatant of B. coagulans KM-1. The bacterium showed the maximum activity for hydrolyzing para-nitrophenyl-${\alpha}$-$\small{D}$-galactopyranoside (pNP-${\alpha}Gal$) at pH 6.0 and $50^{\circ}C$. It hydrolyzed oligomeric substrates such as melibiose, raffinose, and stachyose liberating a galactose residue, indicating that the B. coagulans KM-1 ${\alpha}$-galactosidase hydrolyzed ${\alpha}$-1,6 linkage. The results suggest that the decreased stachyose and raffinose contents in fermented soybean meal are due to the ${\alpha}$-galactosidase activity.

• Journal of Animal Science and Technology
• /
• 제63권6호
• /
• pp.1464-1467
• /
• 2021

Bacillus coagulans CACC 834 was isolated from canine feces, and its potential probiotic properties were characterized by functional genome analysis. Whole-genome sequencing of B. coagulans CACC 834 was performed using the PacBio RSII platforms. The complete genome assembly consisted of one circular chromosome (3.1 Mb) with guanine (G) + cytosine (C) content of 47.1%. Annotation revealed 3,181 protein-coding sequences (CDSs), 30 rRNAs, and 83 tRNAs. Gene associated 11% of the genes were involved in replication, recombination, and repair. We also annotated various stress-related, acid resistance, bile salt resistance and adhesion-related domains in this strain, which likely provide support in exerting probiotic action by survival under gastrointestinal tract. These results add to our comprehensive understanding of B. coagulans and suggest potential mammal-related industrial applications.

• International Journal of Industrial Entomology and Biomaterials
• /
• 제15권1호
• /
• pp.9-16
• /
• 2007

The present study was aimed to screen different antibiotics in vivo for their effects against the bacterium Bacillus coagulans in silkworm Bombyx mori in three experimental conditions viz., a) healthy larvae treated with the antibiotics b) larvae which were first inoculated with Bacillus coagulans immediately after the $2^{nd}$ moult and treated with the antibiotics from 24 hour after inoculation up to the end of the $5^{th}$ instar(pre-inoculated larvae) and c) larvae which were treated with the antibiotics right from hatching up to the end of the $5^{th}$ instar and inoculated with Bacillus coagulans immediately after the $2^{nd}$ moult(post-inoculated larvae). All the antibiotics used in this study stimulated better performance in improving the rearing performance and economic characters of the cocoons in healthy, pre-inoculated and post-inoculated larvae, besides reducing the mortality of infected larvae. Cephelexin and Tetracycline were more effective than the others in their overall performance under all the three experimental conditions. Chloramphenical caused greater increase in the length of the reelable silk filament, but was not as good in elevating the other parameters compared to the remaining antibiotics. Of the four concentrations of antibiotics tested, 2.0% performed better under all the three experimental conditions.

• 한국식품영양과학회지
• /
• 제29권2호
• /
• pp.198-203
• /
• 2000

A highly viscous biopolymer from Bacillus coagulans CE-74 was purified and its rheological properties were studied The rheological properties of biopolymers produced by Bacillus coagulans CE-74 were studied at the temperature ranges with 20~8$0^{\circ}C$, at the concentration of 0.5~4.0%, at the pH ranges from 3 to 1 and at the shear rate fo 7.34~73.38 sec-1. The apparent viscosity of biopolymer was decreased with increasing shear rate, and thereby biopolymer showed pseudoplastic characteristics. Biopolymer solution showed a characteristic of non-Newtonian fluid properties. At the concentration of 1%, the consistency index and the flow behavior index were shown at 2.64 poise. sec11 and 0.8571, respectively. All dispersions were pseudoplastic fluids described accurately by Herschel-Bulkley model. The change of the biopolymer viscosity on pH showed the highest value at the pH 7.0 and it showed lower at acidic conditon that at alkaline condition comparatively.

• 한국미생물·생명공학회지
• /
• 제4권4호
• /
• pp.166-178
• /
• 1976

서로 다른 11주의 Bacillus coagulans와 13종의 Bacillus 속 14주를 deoxyribonucleic acid(DNA)-DNA hybridization method에 의해서 분류학적인 연구를 하였다. 사용한 B. coagulans 11주중 6주는 흙에서(일본 오사까교외) 분리했고, 나머지 5주는 ATCC, IFO에서 authentic strains을 얻어서 사용했다. 사용된 B. coagulans는 Bergey's Manual(8th ed)에 의거 Gordon씨들의 방법으로 동정한 결과 B. coagulans로서 확인되었다. 이렇게 동정된 B. coagulans을 분자 생물학적 차원에서 지금까지의 Conventional taxonomic study와의 관계를 연구하기 위해서 사용한 11주의 B. coagulans중 ATCC 7070을 $^3$H labeled input 즉 standard로 해서 사용했을 때 B. coagulans 내의 intraspecific DNA homology indexes는 76% 이상으로 나타났다. 이와같은 발견은 Bergey's Manual에 의거한 conventional taxonomic study의 결과와 잘 일치하고 있었음으로 새로 분리한 6주와 authentic sources로부터 받은 5주는 같은 group의 B. coagulans라는 사실을 입증해 주었다. 그리고 B. coagulans와 다른 species의 Bacillus 속 즉 B. pumilus(168), B. licheniformis (IFO 12107), B. pumilus(IFO12110), B. firmus(ATCC 14575), B. lentus(ATCC 10840), B. circulans(ATCC 4513), B.macelans(ATCC 8244), B.polymyxa, (ATCC 842), B.sphaericus(ATCC 14577), B.brevis(ATCC 8246, IFO 12334), B.laterosporus(ATCC 64), B. pantothenticus(ATCC 14576) interspecific DNA homology indexes가 각각 2～4%을 보임으로써 B. coagulans는 molecular level면에서 이들 Bacillus 속과는 상동성 관계가 적음을 나타내었다. 반면에 B. coagulans(ATCC 7050)와 E. coli(F-12)와의 상동성은 1%이하였다.